ROYAL BANK OF CANADA - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
90
-89.1%
0.00%
Q2 2023$2,0000.0%825
+22.0%
0.00%
Q1 2023$2,000
-71.4%
676
-52.6%
0.00%
Q4 2022$7,000
-66.7%
1,426
-12.7%
0.00%
Q3 2022$21,000
+2000.0%
1,633
+311.3%
0.00%
Q2 2022$1,000
-95.5%
397
-85.8%
0.00%
Q1 2022$22,000
-75.8%
2,801
-68.4%
0.00%
Q4 2021$91,000
+28.2%
8,859
+68.6%
0.00%
Q3 2021$71,000
+2.9%
5,254
+69.0%
0.00%
Q2 2021$69,000
-2.8%
3,109
+5.1%
0.00%
Q1 2021$71,000
+294.4%
2,958
+192.0%
0.00%
Q4 2020$18,000
+1700.0%
1,013
+704.0%
0.00%
Q3 2020$1,000
-66.7%
126
-6.7%
0.00%
Q2 2020$3,000
-50.0%
135
-76.8%
0.00%
Q1 2020$6,000
-83.3%
582
-57.9%
0.00%
Q4 2019$36,000
+500.0%
1,381
+473.0%
0.00%
Q3 2019$6,000
+50.0%
241
+91.3%
0.00%
Q2 2019$4,000
+100.0%
1260.0%0.00%
Q1 2019$2,0000.0%1260.0%0.00%
Q4 2018$2,000
-93.9%
126
-79.6%
0.00%
Q3 2018$33,000
+450.0%
619
+301.9%
0.00%
Q2 2018$6,000
+100.0%
154
-4.3%
0.00%
Q4 2017$3,000
-81.2%
161
-74.9%
0.00%
Q3 2017$16,0006410.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders